ArticleJournal of nanobiotechnology2025

Hypoxia-responsive core-cross-linked supramolecular nanoprodrug based on dendritic drug-drug conjugates for synergetic anticancer therapy.

Yue Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.